Labcorp Holdings Inc.
LHUSLabcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Founded—IPO year1990As of2026-08-04
Market Cap
$25.54B
Enterprise Value
$32.17B
EV / LTM Revenue
2.3x
EV / NTM Revenue
2.1x
Trading multiples
Enterprise value over trailing (LTM) vs. forward (NTM) fundamentals. Click an LTM cell to chart it.
LTM
trailing
NTM
forward
Revenue
2.1x
Gross Profit
7.6x
EBITDA
12.6x
Classification
- Sector
- Healthcare Services
- Sub-sector
- Diagnostics & Clinical Services
- Listing
- LH
- Country
- US
Annual financials & analyst forecasts
| $M | CY2021 | CY2022 | CY2023 | CY2024 | CY2025 | CY2026E | CY2027E |
|---|---|---|---|---|---|---|---|
| Revenue YoY | — | -17% | -9% | 7% | 7% | 6% | 5% |
| Revenue | $16.12B | $13.36B | $12.16B | $13.01B | $13.95B | $14.73B | $15.45B |
| Gross Profit | $5.62B | $4.03B | $3.36B | $3.62B | $3.94B | — | — |
| Gross Profit Margin | 34.9% | 30.2% | 27.7% | 27.9% | 28.2% | — | — |
| EBITDA | $4.28B | $2.15B | $1.65B | $1.81B | $2.01B | $2.47B | $2.59B |
| EBITDA Margin | 26.5% | 16.1% | 13.6% | 13.9% | 14.4% | 16.8% | 16.8% |
| EBIT | $3.26B | $1.58B | $726M | $1.09B | $1.50B | $1.78B | $1.87B |
| Net Income | $2.38B | $1.28B | $418M | $746M | $877M | $1.52B | $1.64B |
| Free Cash Flow | $2.65B | $1.47B | $848M | $1.10B | $1.21B | — | — |
| FCF Margin | 16.4% | 11.0% | 7.0% | 8.4% | 8.6% | — | — |
| Short-Term Debt | $2M | $301M | $1000M | $1.00B | $696M | — | — |
| Long-Term Debt | $5.42B | $5.04B | $4.05B | $5.33B | $5.77B | — | — |
| Cash & Cash Equivalents | $1.47B | $321M | $537M | $1.52B | $532M | — | — |
| Net Debt | $3.95B | $5.02B | $4.52B | $4.81B | $5.93B | — | — |
| Net Debt / EBITDA | 0.9x | 2.3x | 2.7x | 2.7x | 2.9x | — | — |
| Rule of 40 | — | -6.1% | -2.0% | 15.4% | 15.9% | — | — |
Figures in $M. True calendar years (Jan–Dec) built from quarterly data — income & cash-flow lines summed across the four quarters, balance sheet as of year-end. E columns are calendarized analyst consensus — gross profit, cash flow and balance-sheet lines are not estimated. Net debt = short-term debt + long-term debt − cash & cash equivalents; Rule of 40 = YoY revenue growth + FCF margin.